Conference Coverage

Structural racism tied to psychosis risk in Black people


 

Call to action

Commenting on the findings in an interview, Ned H. Kalin, MD, editor of The American Journal of Psychiatry and professor and chair of the department of psychiatry, University of Wisconsin, Madison, said the study was well done and serves as a “call to action” to address the impact of structural racism on mental health issues and psychiatric diseases.

The article highlights the need for “collecting better data” on structural racism, said Dr. Kalin. “We know it’s a big issue, but we can’t even quantitate it, so we need some fundamental measures to use as a benchmark as we move forward, as we try to make change.”

He noted that racism “is so embedded in one’s experience and in our society that we sort of don’t even think about it as a trauma.”

In psychiatry, for example, trauma is often thought of as a loss or a traumatic event. “We don’t typically think of trauma as an experience that pervades one’s entire life,” but that needs to change, he said. “At the individual level and in the doctor’s office, being sensitive to and aware of these issues is absolutely critical.”

Dr. Anglin and Dr. Kalin have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Preventing arrhythmias and QTc prolongation in COVID-19 patients on psychotropics
Journal of Clinical Outcomes Management
‘Staggering’ increase in COVID-linked depression, anxiety
Journal of Clinical Outcomes Management
New schizophrenia treatment guideline released
Journal of Clinical Outcomes Management
FDA orders stronger warnings on benzodiazepines
Journal of Clinical Outcomes Management
Novel schizophrenia drugs advance through pipeline
Journal of Clinical Outcomes Management
Mental illness tied to increased mortality in COVID-19
Journal of Clinical Outcomes Management
Inflammatory immune findings likely in acute schizophrenia, MDD, bipolar
Journal of Clinical Outcomes Management
‘Landmark’ schizophrenia drug in the wings? 
Journal of Clinical Outcomes Management
Blood pressure meds tied to increased schizophrenia risk
Journal of Clinical Outcomes Management
Antipsychotics protective against COVID-19?
Journal of Clinical Outcomes Management